91 results found.

Atrial Fibrillation Clinical Trial

Boehringer Ingelheim - Recruiting 18 years or older.
- The Comparative Safety and Effectiveness of Warfarin and Dabigatran Utilized in the Department of Defense (DoD) Non-Valvular Atrial Fibrillation (NVAF) Patient Population-A Retrospective Database Analysis.

Atrial Fibrillation Clinical Trial using pantoprazole; Pradaxa (dabigatran etexilate); Pradaxa, within 30 minutes after a meal

Boehringer Ingelheim - Recruiting 18 years or older.
- A Prospective, Open Label Study Evaluating the Efficacy of Two Management Strategies (Pantoprazole 40 mg q.a.m. and Taking Pradaxa® With Food (Within 30 Minutes After a Meal) on Gastrointestinal Symptoms (GIS) in Patients Newly on Treatment With Pradaxa® 150 mg b.i.d., 110 mg b.i.d. or 75 mg b.i.d. for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation (NVAF).
pantoprazole; Pradaxa (dabigatran etexilate); Pradaxa, within 30 minutes after a meal

Stroke, or Atrial Fibrillation Clinical Trial

Boehringer Ingelheim - Recruiting 18 years or older.
- GLORIA-AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III-India and Switzerland).

Atrial Fibrillation Clinical Trial using Pradaxa (Dabigatran etexilate mesilate)

Boehringer Ingelheim - Recruiting 19 years or older.
- A Regulatory Requirement Non-interventional Study to Monitor the Safety and Effectiveness of Pradaxa (Dabigatran Etexilate Mesilate, 110 mg or 150 mg b.i.d.) in Korean Patients With Non-valvular Atrial Fibrillation(SPARK: Safety Study of Pradaxa in AF Patients by Regulatory Requirement of Korea).
Pradaxa (Dabigatran etexilate mesilate)

Stroke, or Atrial Fibrillation Clinical Trial

Boehringer Ingelheim - Recruiting 18 years or older.
- GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III).

Atrial Fibrillation Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 18 years or older.
- Satisfaction and Quality of Life in Patients With a Diagnosis of Non Valvular Atrial Fibrillation Who Take Rivaroxaban for Stroke Prevention.
Rivaroxaban (Xarelto, BAY59-7939)

Stroke, or Atrial Fibrillation Clinical Trial

Boehringer Ingelheim - Recruiting 18 years or older.
- GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase II/III - EU/EEA Member States).

Paroxysmal Atrial Fibrillation Clinical Trial using Ablation

Toray Industries (America), Inc. - Recruiting 18 years or older.
- A Pilot Study Evaluating the Safety and Effectiveness of the Toray Satake Balloon Thermal Ablation System for the Treatment of Paroxysmal Atrial Fibrillation.
Ablation

Persistent Atrial Fibrillation Clinical Trial using Convergent Procedure EPi-Sense-AF Guided Coagulation System; Endocardial Catheter Ablation

nContact Surgical Inc. - Recruiting 18 years to 80 years.
- Convergence Of Epicardial And Endocardial Radiofrequency (RF) Ablation For The Treatment Of Symptomatic Persistent AF.
Convergent Procedure EPi-Sense-AF Guided Coagulation System; Endocardial Catheter Ablation

Atrial Fibrillation, or Acute Coronary Syndrome Clinical Trial using Ticagrelor + Apixaban + ASA; Ticagrelor + Apixaban

Medical University of Vienna - Recruiting 18 years to 40 years.
- The Effect of Ticagrelor and Apixaban With or Without Acetylsalicylic Acid on Markers of Coagulation Activation at the Site of Thrombus Formation in Vivo in Healthy Male Subjects and in an ex Vivo Perfusion Chamber Model at High and Low Shear Rate.
Ticagrelor + Apixaban + ASA; Ticagrelor + Apixaban

Atrial Fibrillation Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 18 years or older.
- Belgian Real Life Non-interventional Study (NIS) on Xarelto® in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism (BOX-AF).
Rivaroxaban (Xarelto, BAY59-7939)

Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, H Clinical Trial using Renal Artery Ablation Catheter; Cardiac Ablation

St. Jude Medical - Recruiting 18 years or older.
- A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence.
Renal Artery Ablation Catheter; Cardiac Ablation

Atrial Fibrillation or Pulmonary Embolism, Need of Long Term Oral Clinical Trial using Rivaroxaban or Marcumar

RWTH Aachen University - Recruiting 18 years or older.
- Influence of Rivaroxaban Compared to Vitamin K Antagonist Treatment Upon Development of Cardiovascular Calcification in Patients With Atrial Fibrillation and/ or Pulmonary Embolism.
Rivaroxaban or Marcumar

Atrial Fibrillation Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 18 years or older.
- An Open-label, International, Multicenter, Interventional Study Exploring the Efficacy of Once-daily Oral Rivaroxaban (BAY 59-7939) for the Treatment of Left Atrial/Left Atrial Appendage Thrombus in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter.
Rivaroxaban (Xarelto, BAY59-7939)

Paroxysmal Atrial Fibrillation Clinical Trial using Catheter ablation for the treatment of paroxysmal atrial fibrillation

St. Jude Medical - Recruiting 18 years or older.
- A Prospective, Randomized, Multicenter, Interventional Study to Evaluate the Safety and Effectiveness of the TactiCath Percutaneous Ablation Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation Using Contact Force Assisted Radiofrequency Ablation.
Catheter ablation for the treatment of paroxysmal atrial fibrillation

Mitral Valvulopathy, or Atrial Fibrillation Clinical Trial using EPICOR; Amiodarone

Centre Hospitalier Universitaire de Saint Etienne - Recruiting 18 years or older.
- Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology (EPICOR) or Drug Therapy (Cordarone) for Patients With AF Requiring Mitral Valve Surgery.
EPICOR; Amiodarone

Persistent Atrial Fibrillation Clinical Trial using HeartLight(TM) Laser Balloon; irrigated radiofrequency current ablation

Cardioangiologisches Centrum Bethanien - Recruiting 18 years to 80 years.
- Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation.
HeartLight(TM) Laser Balloon; irrigated radiofrequency current ablation

Persistent Atrial Fibrillation, or Longstanding Persistent Atrial Clinical Trial using Synergy Ablation System

AtriCure, Inc. - Recruiting 18 years or older.
- AtriCure Synergy Ablation Lesions for Non-Paroxysmal Forms of Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery.
Synergy Ablation System

Atrial Fibrillation, or Coronary Artery Disease Clinical Trial using This is an observational study.

East and North Hertfordshire NHS Trust - Recruiting 18 years or older.
- Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis.
This is an observational study.

Atrial Fibrillation, Ablation, or C Reactive Protein Clinical Trial using Colchicine, 0.6 mg PO BID; Matching placebo

Mayo Clinic - Recruiting N/A or older.
- Impact and Time Course of Colchicine Therapy on C-reactive Protein Elevation in Chronic Atrial Fibrillation (AF) and Post AF Ablation.
Colchicine, 0.6 mg PO BID; Matching placebo

Atrial Fibrillation, or Percutaneous Coronary Intervention Clinical Trial using rivaroxaban 2.5 mg; rivaroxaban 15 mg; rivaroxaban 10 mg; aspirin (ASA); vitamin K antagonist (VKA); clopidogrel; prasugrel; ticagrelor

Janssen Scientific Affairs, LLC - Recruiting 18 years or older.
- An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention.
rivaroxaban 2.5 mg; rivaroxaban 15 mg; rivaroxaban 10 mg; aspirin (ASA); vitamin K antagonist (VKA); clopidogrel; prasugrel; ticagrelor

HIV, Atrial Fibrillation, or Venous Thromboembolism Clinical Trial using Ritonavir; Cobicistat

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 70 years.
- The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers.
Ritonavir; Cobicistat

Atrial Fibrillation Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 18 years or older.
- XANTUS-EL, Xareltor on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A Noninterventional Study.
Rivaroxaban (Xarelto, BAY59-7939)

Atrial Fibrillation Clinical Trial using Pradaxa, dabigatran etexilate

Boehringer Ingelheim - Recruiting 18 years or older.
- A Prospective, Open Label Study to Evaluate the Pharmacokinetics of Dabigatran in Non-valvular Atrial Fibrillation (NVAF) Patients With Severely Impaired Renal Function on Dabigatran Etexilate 75 mg BID Therapy.
Pradaxa, dabigatran etexilate

Atrial Fibrillation Clinical Trial using No Amiodarone

Inova Health Care Services - Recruiting 18 years or older.
- Anti-Arrhythmic Medication (Amiodarone) Post Surgical Ablation for Atrial Fibrillation - Is it Necessary?.
No Amiodarone

Atrial Fibrillation Clinical Trial using `MyDiagnostick

UMC Utrecht - Recruiting N/A or older.
- Screening for Silent Atrial Fibrillation During Influenza Vaccination.
`MyDiagnostick

Atrial Fibrillation Clinical Trial using rivaroxaban; uninterrupted vitamin K antagonist (VKA)

Janssen Scientific Affairs, LLC - Recruiting 18 years or older.
- A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation.
rivaroxaban; uninterrupted vitamin K antagonist (VKA)

Atrial Fibrillation Clinical Trial using Patients with Atrial Fibrillation

Janssen Scientific Affairs, LLC - Recruiting 21 years or older.
- Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (Orbit-AF II).
Patients with Atrial Fibrillation

Coronary Artery Disease, or Atrial Fibrillation Clinical Trial using 6 weeks; 6 months

Deutsches Herzzentrum Muenchen - Recruiting 18 years or older.
- Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting.
6 weeks; 6 months

Atrial Fibrillation Clinical Trial using WATCHMAN LAA Closure Technology

Boston Scientific Corporation - Recruiting 18 years or older.
- WATCHMAN Asia Pacific Registry.
WATCHMAN LAA Closure Technology

Arrhythmias, Cardiac, Atrial Fibrillation, or Bundle Branch Block Clinical Trial

Essentia Health - Recruiting 18 years or older.
- Proof-of-concept Study to Assess Ventricular Activation Timing During Atrial Fibrillation, or Bundle Branch Block and Sinus Rhythm.

Atrial Fibrillation Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 18 years or older.
- Xareltor on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Asia: A Non-interventional Study.
Rivaroxaban (Xarelto, BAY59-7939)

Hyperthyroidism, or Atrial Fibrillation Clinical Trial

Karolinska Institutet - Recruiting N/A or older.
- Thumb-ECG Ambulant Screening for Atrial Fibrillation in Hyperthyroid Patients Treated With Radioiodine.

Atrial Fibrillation Clinical Trial using Canakinumab; Placebo

University Hospital, Basel, Switzerland - Recruiting 50 years or older.
- Canakinumab for the Prevention of Recurrences After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation (CONVERT-AF) Trial - A Randomized Double Blind Placebo Controlled Study.
Canakinumab; Placebo

Atrial Fibrillation Clinical Trial using nMARQ Navigation Catheters; NaviStar ThermoCool Catheters

Biosense Webster, Inc. - Recruiting 18 years or older.
- reMARQable nMARQT Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation.
nMARQ Navigation Catheters; NaviStar ThermoCool Catheters

Atrial Fibrillation, or Subclinical Hyperthyroidism Clinical Trial

Karolinska Institutet - Recruiting 18 years or older.
- Observational Prospective Case-control Study on Prevalence and Impact of Subclinical Hyperthyroidism in Patients Undergoing Atrial Fibrillation Ablation.

Atrial Fibrillation, Hypertension, Diabetes, Chronic Heart Failur Clinical Trial using Medtronic Reveal XT implantable loop recorder

Medical University of Graz - Recruiting 18 years or older.
- Randomized Controlled Trial to Evaluate Implanted Event Recorders for the First Diagnosis of Atrial Fibrillation in High-risk Patients.
Medtronic Reveal XT implantable loop recorder

Atrial Fibrillation Clinical Trial using atrial tissue

University of Pittsburgh - Recruiting 18 years or older.
- Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery and Tissue Banking.
atrial tissue

Symptomatic Paroxysmal Atrial Fibrillation (PAF) Clinical Trial using Electrical isolation of the pulmonary veins; Electrical isolation of pulmonary veins

Medtronic International Trading Sarl - Recruiting 18 years to 75 years.
- A Controlled, Prospective, Non-Inferiority, Parallel-Group, Randomised, Interventional, Open, Blinded Outcome Assessment (PROBE-Design), Multi-centre Trial, Comparing Efficacy and Safety of Isolation of the Pulmonary Veins With a Cryoballoon Catheter Versus a Radiofrequency Ablation With a ThermoCool Catheter in Patients With Paroxysmal Atrial Fibrillation.
Electrical isolation of the pulmonary veins; Electrical isolation of pulmonary veins

Atrial Fibrillation Clinical Trial using maze procedure; mitral valve surgery; left atrial reduction

Meshalkin Research Institute of Pathology of Circulation - Recruiting 18 years to 65 years.
- Left Atrium Reduction Versus no Left Atrium Reduction for Patients With Enlarged Left Atria and Persistent or Long Standing Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery.
maze procedure; mitral valve surgery; left atrial reduction

Stroke,, or Embolism Clinical Trial using Rivaroxaban ( Xarelto, BAY59-7939)

Bayer - Recruiting 18 years or older.
- Prospective Multicenter Observational Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients.
Rivaroxaban ( Xarelto, BAY59-7939)

Atrial Fibrillation Clinical Trial using 1g of F373280; Placebo

Pierre Fabre Medicament - Recruiting 18 years or older.
- Efficacy and Safety Study of F373280 for Maintenance of Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation and Chronic Heart Failure. International, Multicentric, Randomised, Double-blind, Placebo Controlled Study..
1g of F373280; Placebo

Arterial Hypertension, or Diabetes Mellitus Clinical Trial using Conventional Holter monitoring; Implantable loop recorder

Odense University Hospital - Recruiting 65 years to 90 years.
- Detection of Subclinical Atrial Fibrillation in High Risk Patients (> 65 Years, Hypertension, Diabetes Mellitus) Using Implantable Loop Recorder.
Conventional Holter monitoring; Implantable loop recorder

Atrial Fibrillation, or Atrial Flutter Clinical Trial using Ramipril; Placebo

Centre Hospitalier Universitaire de Saint Etienne - Recruiting 18 years or older.
- Prevention of Atrial Fibrillation by the Prescription of Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter.
Ramipril; Placebo

Atrial Fibrillation, or AFib Clinical Trial using AtriClip LAA Exclusion Device

AtriCure, Inc. - Recruiting 18 years to 80 years.
- Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated.
AtriClip LAA Exclusion Device

Patients With Atrial Fibrillation at Risk for Thrombus Formation, Clinical Trial

Boston Scientific Corporation - Recruiting 18 years or older.
- Registry on WATCHMAN Outcomes in Real-Life Utilization.

Atrial Fibrillation Clinical Trial

Boehringer Ingelheim Pharmaceuticals - Recruiting 18 years or older.
- A Description of Warfarin and NOAC Utilization Patterns Including Initiation, Switching, and Discontinuation.

Atrial Fibrillation, Stroke, Hypertension, or Diabetes Clinical Trial using LOOP recorder (Medtronic LINQ device)

Rigshospitalet, Denmark - Recruiting 70 years to 90 years.
- Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-risk Individuals..
LOOP recorder (Medtronic LINQ device)

Paroxysmal Atrial Fibrillation (PAF) Clinical Trial using Medtronic Arctic Frontr Cardiac CryoAblation System

Medtronic Atrial Fibrillation Solutions - Recruiting 18 years or older.
- Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS).
Medtronic Arctic Frontr Cardiac CryoAblation System

Heart Failure Clinical Trial using Implantation of CRT device; Implantation of conventional VVI(R) pacemaker

Almazov Federal Center of Heart, Blood and Endocrinology - Recruiting 18 years to 75 years.
- Variant of Stimulation in Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure.
Implantation of CRT device; Implantation of conventional VVI(R) pacemaker

Complication of Coronary Artery Bypass Graft, or Atrial Fibrillat Clinical Trial using Two sites cryoablation

Seoul St. Mary's Hospital - Recruiting N/A or older.
- Atrial Fibrillation Prevention in Post Coronary Artery Bypass Graft Surgery With Cryoablation for Ganglionic Plexi.
Two sites cryoablation

Paroxysmal Atrial Fibrillation Clinical Trial using cavotricuspid isthmus ablation; control group

Seoul St. Mary's Hospital - Recruiting N/A or older.
- Effect of Cavotricuspid Isthmus Ablation in Patients Without History of Typical Flutter During Ablation for Paroxysmal Atrial Fibrillation.
cavotricuspid isthmus ablation; control group

Heart Attack, Cardiac Arrest, Congestive Heart Failure, Atrial Fi Clinical Trial

Washington University School of Medicine - Recruiting 18 years or older.
- SATISFY-SOS: Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys.

Atrial Fibrillation, Paroxysmal Atrial Fibrillation, or Persisten Clinical Trial using OPC-108459; Placebo

Otsuka Pharmaceutical Development & Commercialization, Inc. - Recruiting 18 years to 85 years.
- A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation.
OPC-108459; Placebo

Atrial Fibrillation Clinical Trial using Biosense Webster irrigated tip catheter; Pulmonary vein isolation; ICE catheter placed through one of two existing 8F sheaths

Wellmont CVA Heart Institute - Recruiting 18 years to 80 years.
- ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation.
Biosense Webster irrigated tip catheter; Pulmonary vein isolation; ICE catheter placed through one of two existing 8F sheaths

Cardiothoracic Surgery, or Post-operative Atrial Fibrillation Clinical Trial using Atorvastatin 20 mg; Atorvastatin 80 mg

Creighton University - Recruiting 19 years or older.
- Intensive Statin Therapy Effect on Incidence of Post-Operative Atrial Fibrillation.
Atorvastatin 20 mg; Atorvastatin 80 mg

Atrial Fibrillation Clinical Trial using Pulmonary Vein Isolation procedure

University of Pennsylvania - Recruiting 18 years or older.
- Second Randomization Study to Assess Efficacy of Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial Fibrillation: RASTA XT Study.
Pulmonary Vein Isolation procedure

Atrial Fibrillation, Deep Vein Thrombosis, Cardiac Valvular Insuf Clinical Trial

University of Puerto Rico - Recruiting 18 years to 90 years.
- Pharmacogenetics of Warfarin in Puerto Rican Patients Using a Physiogenomics Approach..

Persistent Atrial Fibrillation Clinical Trial using Medtronic Phased RF Ablation System

Medtronic Atrial Fibrillation Solutions - Recruiting 18 years to 70 years.
- Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation.
Medtronic Phased RF Ablation System

Atrial Fibrillation Clinical Trial using Use of the Achieve catheter followed by ICE-guided mapping catheter

University of Pittsburgh - Recruiting 18 years or older.
- Mechanisms and Patterns of Atrial Fibrillation Recurrence After Cryoballoon Ablation.
Use of the Achieve catheter followed by ICE-guided mapping catheter

Ventricular Tachycardia, or Atrial Fibrillation Clinical Trial using Ethanol; Ablation

The Methodist Hospital System - Recruiting 18 years to 85 years.
- Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation.
Ethanol; Ablation

Atrial Fibrillation Clinical Trial using Electrical-first; Chemical-first

University of British Columbia - Recruiting 19 years to 85 years.
- A Randomized Crossover Trial to Evaluate Electrical Versus Chemical Cardioversion in Patients With Acute Atrial Fibrillation.
Electrical-first; Chemical-first

Hypertension, Hypertensive Heart Disease, Atrial Fibrillation, or Clinical Trial using Renal denervation; Medical therapy

Pace Clinic - Recruiting 55 years or older.
- Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study.
Renal denervation; Medical therapy

Atrial Fibrillation Clinical Trial using WATCHMAN LAA Closure Technology

Boston Scientific Corporation - Recruiting 18 years or older.
- Continued Access to PREVAIL (CAP2)- WATCHMAN Left Atrial Appendage (LAA) Closure Technology.
WATCHMAN LAA Closure Technology

Tachycardia, Atrioventricular Nodal Reentry Clinical Trial using Freezorr Cardiac Cryoablation Catheter CryoConsole System

Medtronic Atrial Fibrillation Solutions - Recruiting 18 years or older.
- CryoCath Freezor CryoAblation Catheter System (CRYOFACTS).
Freezorr Cardiac Cryoablation Catheter CryoConsole System

Migraine, or Atrial Fibrillation Clinical Trial using Radiofrequency catheter ablation

Texas Cardiac Arrhythmia Research Foundation - Recruiting 18 years to 75 years.
- Effect of Catheter Ablation on the Prevalence, Clinical Manifestation and MRI Findings of Migraine in AF Patients With or Without a Previous History of Migraine.
Radiofrequency catheter ablation

Heart; Dysfunction Postoperative, Cardiac Surgery, Genetic Predis Clinical Trial

Brigham and Women's Hospital - Recruiting 20 years to 90 years.
- Identification of Genomic Predictors of Adverse Events After Cardiac Surgery.

Atrial Fibrillation Clinical Trial using Pulmonary vein antrum isolation (PVAI); PVAI plus left atrial posterior wall (LAPW) isolation

Texas Cardiac Arrhythmia Research Foundation - Recruiting 18 years or older.
- Freedom From Atrial Arrhythmia in Atrial Fibrillation Patients After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation.
Pulmonary vein antrum isolation (PVAI); PVAI plus left atrial posterior wall (LAPW) isolation

Hypertension, or Atrial Fibrillation Clinical Trial using renal sympathetic denervation; drug; Direct-Current Cardioversion

The First Hospital of Nanjing Medical University - Recruiting 18 years to 75 years.
- Safety and Effectiveness Study of Percutaneous Catheter-based Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation.
renal sympathetic denervation; drug; Direct-Current Cardioversion

Heart Failure Clinical Trial using Atrial Fibrillation ablation; Amiodarone

Texas Cardiac Arrhythmia Research Foundation - Recruiting 18 years or older.
- Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICD/CRTD.
Atrial Fibrillation ablation; Amiodarone

Atrial Fibrillation, Heart Failure, Stroke, or Cardiovascular Dis Clinical Trial

Vestre Viken Hospital Trust - Recruiting 62 years to 62 years.
- Akershus Cardiac Examination Study 1950 - a Cohort Study on Cardiovascular Disease in 60-65 Year-old Subjects.

Hypertension, or Atrial Fibrillation Clinical Trial using renal sympathetic denervation

The First Hospital of Nanjing Medical University - Recruiting 18 years to 75 years.
- Safety and Effectiveness Study of Percutaneous Catheter-based Sympathetic Denervation of the Renal Arteries in Patients With Hypertension and Paroxysmal Atrial Fibrillation.
renal sympathetic denervation

Paroxysmal Atrial Fibrillation Clinical Trial using pilsicainide; other class IC antiarrhythmic drug

Korea University - Recruiting 18 years to 80 years.
- Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation Compared With Other Class IC Anti-arrhythmic Drugs.
pilsicainide; other class IC antiarrhythmic drug

Atrial Fibrillation, Mitral Valve Insufficiency, or Mitral Valve Clinical Trial using Mitral valve surgery with ligation/excision of left atrial appendage with ablation; Mitral valve surgery with ligation/excision of left atrial appendage

Mount Sinai School of Medicine - Recruiting 18 years or older.
- Surgical Ablation Versus No Surgical Ablation for Patients With Persistent or Longstanding Persistent Atrial Fibrillation (AF) Undergoing Mitral Valve Surgery.
Mitral valve surgery with ligation/excision of left atrial appendage with ablation; Mitral valve surgery with ligation/excision of left atrial appendage

Atrial Fibrillation Clinical Trial using Ranolazine; Matching placebo

University of Oklahoma - Recruiting 21 years or older.
- Ranolazine for the Prevention of Recurrent Persistent Atrial Fibrillation After Electrical Cardioversion: a Pilot Study.
Ranolazine; Matching placebo

Deep Vein Thrombosis Leg, or Stroke (in Patients With Atrial Fibr Clinical Trial using DPOC-4088; Placebo

Diakron Pharmaceuticals - Recruiting 18 years to 50 years.
- A Randomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics (PK), Pharmacodynamics (PD), PK/PD Characteristics and Safety of Multiple Once-daily Oral Dosing of DPOC-4088 in Healthy Young Male Subjects.
DPOC-4088; Placebo

Atrial Fibrillation Clinical Trial using Ablation

Royal Brompton & Harefield NHS Foundation Trust - Recruiting 18 years to 80 years.
- The Role of Contact Force Sensing in Electrical Pulmonary Vein Isolation When Conducting Atrial Fibrillation Ablation.
Ablation

Chronic Stable Angina, Coronary Artery Disease, Atrial Fibrillati Clinical Trial using ranolazine; placebo

Cardiovascular Consultants of Nevada - Recruiting 35 years or older.
- Safety of Amiodarone and Ranolazine Together in Patients With Stable Angina.
ranolazine; placebo

Atrial Fibrillation Clinical Trial

University Medical Centre Groningen - Recruiting 18 years or older.
- Identification of a Risk Profile to Guide Atrial Fibrillation Therapy.

Atrial Fibrillation, or Heart Failure Clinical Trial using Catheter ablation of persistent atrial fibrillation; Medical treatment alone

Barts & The London NHS Trust - Recruiting 18 years or older.
- Catheter Ablation Versus Medical Treatment of AF in Heart Failure.
Catheter ablation of persistent atrial fibrillation; Medical treatment alone

Atrial Fibrillation Clinical Trial using low dose diltiazem

Seoul National University Hospital - Recruiting 18 years or older.
- .
low dose diltiazem

Atrial Fibrillation, Thromboembolism, or Cerebrovascular Accident Clinical Trial using Left Atrial Appendage Ligation

London Health Sciences Centre - Recruiting N/A or older.
- Concurrent Prophylactic Left Atrial Appendage Exclusion: A Randomized Controlled Trial.
Left Atrial Appendage Ligation

Atrial Fibrillation, or Tachycardia Clinical Trial using pulmonary vein isolation; pulmonary vein isolation with additional ablation of fragmented potentials

Asklepios proresearch - Recruiting 18 years to 75 years.
- Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation - Pulmonary Vein Isolation With or Without Ablation of Complex Fragmented Atrial Potentials.
pulmonary vein isolation; pulmonary vein isolation with additional ablation of fragmented potentials

Atrial Fibrillation Clinical Trial using Pulmonary vein isolation with radiofrequency current

Asklepios proresearch - Recruiting 30 years to 75 years.
- Ablation at St. George Hospital - Prospective Randomized Comparison of Manual and Mechanical Remote Robotic Catheter Ablation for Drug-Refractory Atrial Fibrillation.
Pulmonary vein isolation with radiofrequency current

Paroxysmal Atrial Fibrillation Clinical Trial using Circumferential Antral Ablation; Segmental Antral ablation

Lawson Health Research Institute - Recruiting 18 years or older.
- Randomized Trial of Segmental Versus Circumferential Antral Ablation in Paroxysmal Atrial Fibrillation.
Circumferential Antral Ablation; Segmental Antral ablation

Venous Thrombosis, Pulmonary Embolism, or Atrial Fibrillation Clinical Trial using Warfarin

Hadassah Medical Organization - Recruiting 18 years or older.
- Warfarin Induction Regimen Based Upon CYP2C9, VKORC1 Factor VII Genotyping, PMR and INR Monitoring, as Compared to the Conventional Regimen: a Prospective Controlled Study.
Warfarin

Atrial Fibrillation Clinical Trial using Exercise

University of Texas Southwestern Medical Center - Recruiting N/A or older.
- The Effect of Low Intensity Exercise on Quality of Life and Hemodynamics in Patients With Permanent Atrial Fibrillation.
Exercise

Atrial Fibrillation, or Lung Cancer Clinical Trial using Amiodarone; Control arm, standard care

Beth Israel Deaconess Medical Center - Recruiting 18 years or older.
- Phase III Study of Preoperative Amiodarone for Prevention of Atrial Fibrillation After Lung Resection.
Amiodarone; Control arm, standard care

Atrial Fibrillation Clinical Trial using Catheter Ablation; Surgical Ablation

St. Antonius Hospital - Recruiting 30 years to 70 years.
- Atrial Fibrillation: Ablation or Surgical Treatment; A Randomized Study Comparing Non-Pharmacologic Therapy in Patients With Drug-Refractory Atrial Fibrillation.
Catheter Ablation; Surgical Ablation

Atrial Fibrillation Clinical Trial

National Taiwan University Hospital - Recruiting 20 years to 90 years.
- .